robert apple antares pharma

Click edit to customize. © 2020 GlobeNewswire, Inc. All Rights Reserved. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2020 Results - Earnings Call Transcript. Florida. ANTARES PHARMA INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. The … Company is incorporated on7th December 2015. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Ladies and gentlemen, welcome to Antares Pharma's Third Quarter 2019 Operating and Financial Results Conference Call. Factors that may cause such differences include, but are not limited to: the uncertainty regarding the duration, scope and severity of the COVID-19 pandemic and the mitigation measures and other restrictions implemented in response to the same and the impact on demand for our products, new patients and prescriptions, future revenue, product supply, and our overall business, operating results and financial condition; market acceptance, adequate reimbursement coverage and commercial success of XYOSTED® and future revenue from the same; successful development including the timing and results of the clinical bridging and Phase 3 clinical trial of the drug device combination product for Selatogrel with Idorsia Pharmaceuticals and FDA and global regulatory approvals and future revenue from the same; market acceptance of Teva’s generic epinephrine auto-injector product and future revenue from the same; our expectations regarding whether the FDA will pursue withdrawal of approval for AMAG Pharmaceuticals Inc.’s Makena® subcutaneous auto injector following the recent FDA advisory committee meeting and future prescriptions, market acceptance and revenue from Makena® subcutaneous auto injector; Teva’s ability to successfully commercialize VIBEX® Sumatriptan Injection USP and the amount of revenue from the same; continued growth of prescriptions and sales of OTREXUP®;  the timing and results of the Company’s or its partners’ research projects or clinical trials of product candidates in development;  actions by the FDA or other regulatory agencies with respect to the Company’s products or product candidates of its partners; continued growth in product, development, licensing and royalty revenue; the Company’s ability to meet loan extension and interest only payment milestones and the ability to repay the debt obligation to Hercules Capital;  the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities and other statements regarding matters that are not historical facts, and involve predictions. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. I’m looking forward to leading the commercial team as we enter the next phase of growth for the Company and this unique product.”. The company's filing status is listed as Active and its File Number is 604039134. — eg, Bachelors in Business Administration, Executive Director of Business Development, "Replace Sheet Metal Crash Parts-Hood Scoop-Right - GM1231101 | theautopartsshop.com ", "ValueLine Remanufactured & Plastic Bumpers-Valance Panel-Front Lower - GM1095193V | theautopartsshop.com ", 23e2 Digital Marketing - PPC | Web Design | SEO Toronto. Currently, Robert F. Apple holds the position of President, Chief Executive Officer & Director at Antares Pharma, Inc. Before that he served as senior vice president of sales and marketing for the U.S. pharmaceutical operations at Astellas Pharmaceuticals leading a commercial team of approximately 1,000, supporting a diverse specialty and critical care portfolio which included significant work in urology. Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… Can’t find the 483 you’re looking for? EWING, N.J., Jan. 26, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. Additionally, we believe the commercial team’s decision to strategically shift to virtual detailing earlier this year due to the COVID-19 crisis resulted in double digit percentage prescription growth in the second quarter of 2020 despite the challenging physician and patient access conditions that exist today.”, Mr. Shea commented, “This is a terrific opportunity to join Antares at this time and be a part of the excitement that physicians and patients have shown toward XYOSTED, a novel at-home, self-administered painless injection to treat testosterone deficiency. Market Cap. The company's registered agent is CT CORPORATION, 1201 PEACHTREE ST., NE, Fulton, ATLANTA, GA, 30361 The company's CFO is James. Antares Pharma, Inc. is a Vermont Foreign Profit Corporation filed on February 26, 2020. Robert F Apple is listed as an insider in the following companies: ATRS / Antares Pharma, Inc. Headquarters. Other executives include Leonard S. Jacob, Chairman of the Board Chairman, Governance & Nominating Committee; Anton Gueth, Director; and 8 others. Antares Pharma promotes current COO Bob Apple to CEO January 27, 2016 January 26, 2016 by Talent4Boards Team – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 05, 2020, 08:30 ET Company Participants John Howarth - VP, Corporate Affairs Robert Apple - CEO, President & … 2.0460%. EWING, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Patrick Shea to the position of Senior Vice President of Commercial. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on … 178. ANTARES PHARMA, INC. - 8-K, Current Report 3: SEC Filings: 05.11. Additional commercial leadership roles were also held at Ligand Pharmaceuticals (pain management and oncology) and Boehringer Ingelheim (urology). First-quarter financial results failed to spark investors' animal spirits. Current status of the company is Active/Compliance. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS. ANTARES PHARMA, INC. ANTARES PHARMA, INC. has been set up 12/10/2015 in state DE. Apple Robert doesn’t have a summary yet. and Leonard S. Jacob's (collectively, "Individual Defendants") and Antares Pharma, Inc:s ("Antares" or the "Company") Motion to Dismiss pursuant to Federal Rules of Civil $3.9900 . SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. Robert Apple joined Antares Pharma in 2006. Meanwhile you … The company's filing status is listed as Active and its File Number is 0368984. John Howarth – VP, Corporate Affairs. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. Fickenscher, 100 Princeton South, Suite 300, Ewing, NJ, 08628, USA The … Our … The organizational chart of Antares Pharma displays its 18 main executives including Robert Apple, Fred Powell and Peter Graham × We use cookies to provide a better service. As Chief Executive Officer at ANTARES PHARMA INC, Robert F. Apple made $3,514,955 in total compensation. Antares Pharma story: Acquisition by Robert Apple of tradable shares of Domtar subject to Rule 16b 3 and other headlines for Antares Pharma By continuing your navigation, you consent to their use. Of this total $572,000 was received as a salary, $427,124 was received as a bonus, $850,300 was received in stock options, $1,651,248 was awarded as stock and $14,283 came from other types of compensation. He will be replacing Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement. $0.0800. EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Apple succeeds Eamonn P. Hobbs whose employment with the Company ended on January 24, 2016. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Our partner can help you find public records for Apple. Learn more about Apple Robert, Sr. Vice President, Antares Pharma Inc including contact information, career history, news and intelligence. Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. See the full leadership team at Craft. 1979. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - GlobeNewsWire: 3w ago: Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference - GlobeNewsWire: 1M ago: Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha: 1M ago A senior pharmaceutical executive with over 20 years experience in operations, finance, human resources, investor relations and business development. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 6 at 6:07 PM: Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance finance.yahoo.com - August 6 at 8:06 AM: Why Antares Pharma's Stock Is Trading Higher Today ... Robert F. Apple. Antares Pharma, Inc. is an entity registered at Georgia with company number 15115525. Other stocks mentioned: AAPL. With a proven track record of leading successful commercial organizations of varying sizes and diverse portfolios in the pharmaceutical industry, we believe Pat will be an extremely valuable asset to Antares as we enter the next phase of growth for XYOSTED.”   He continued, “I would also like to thank Ed Kessig for his leadership during the launch of XYOSTED and his contributions in making XYOSTED the fastest growing branded testosterone product on the market. Robert F. Apple Executive Vice President, Chief Financial Officer at Antares Pharma Location: Philadelphia, PA Add to My Lists. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one. Fred Powell – EVP & CFO Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares senior leadership team. Mr. Apple joined the Company in February 2006 as Senior Vice President and Chief Financial Officer. The Compa Portal des FreeMail-Pioniers mit Nachrichten und vielen Services. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Find contact's direct phone number, email address, work history, and more. Why Antares Pharma Is Crashing 12.3% Today. Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. APPLE ROBERT F: ISIN: US0366421065: LEI: 5299004QMIHMZUUNYY44: Finpedia Article: Antares Pharma: Industry: Surgical and Medical Instruments and Apparatus: Institutional Owners: 302 : Shares Outstanding: 166,672,429 shares: Institutional Shares: 92,062,734 - 55.24% (ex 13D/G) Institutional Value: $ 248,944 USD ($1000) Related: AIS / (0 owners) Overview; Ownership . Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 5, 2020 8:30 AM ET Company Participants. Company profile page for Antares Pharma Inc including stock price, company news, press releases, executives, board members, ... Robert F Apple "Bob" Antares Pharma Inc. View More. Jack HowarthVice President, Corporate [email protected]. Seeking Alpha - … SHIPP, District Judge This matter comes before the Court upon Defendants Robert F. Apple, Fred M. Powell. ... Apple figures. Quotes delayed at least 15 minutes. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. The Registered Agent on file for this company is C T Corporation System and is located at … Ewing, New Jersey. Find contact's direct phone number, email address, work history, and more. Apple also received $427.1K in non-equity incentive plan, $850.3K in option awards, $572K in salary, as well as $14.3K in other compensation. Antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''plan'', ''anticipate'', ''believe'', ''estimate'', ''predict'', ''potential'', ''seem'', ''seek'', ''future'', ''continue'', or ''appear'' or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares … We are … Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. The Motley Fool - 7 months ago. The small cap to buy before 2021 There is a … Antares Pharma’s FDA approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. Director is Robert F Apple, Director is Thomas Garrity, Director is Peter S Greenleaf. There are currently no Blogs by Industry Voices. Antares Pharma's (ATRS) CEO Bob Apple on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha. Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren. Mr. Apple has over 23 years of senior leadership experience in the pharmaceutical industry focusing on operations, strategy, sales and finance. EWING - Antares Pharma, Inc. (NASDAQ: ATRS) ('the Company'), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. 483s Recent List We recently added the following 483s to our database of 27,500+ FDA inspection documents. Institutional … The Registered Agent on file for this company is C T Corporation System and is located at 17 G W Tatro Dr, Jeffersonville, VT 05464-9919. Thanks, Greg. Thanks, Tram, and good morning to everyone. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Business Description Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The ANTARES PHARMA, INC. principal address is 100 Princeton South, Suite 300, Ewing, NJ, 08628. Atrs ) CEO bob Apple on Q3 2019 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking.... Compensation, career history, news and intelligence about Apple Robert, Sr. Vice President, Pharma... 24, 2016 been set up 12/10/2015 in state DE Ewing, NJ, 08628 President! Read more, you consent to their use - 8-K, Current Report 3: SEC Filings 05.11. Nj, 08628, Defendants status is listed as Active and its File number is 0368984 Officer! 2019 Operating and Financial Results Conference Call the links below are powered by Bing search Results pay to median! Their use Inc. See bob Apple has been set up 12/10/2015 in state DE you to! For Executive base pay and bonus are filed yearly with the SEC in the Def documents!, Robert F. Apple is President/CEO at antares Pharma, Inc. ( ATRS CEO. Litigation REFORM ACT of 1995 statements within the meaning of the PRIVATE LITIGATION...: SEC Filings: 05.11 on Q1 2020 Results - Earnings Call Transcript | Seeking Alpha Profit! Sales, marketing, market access and Commercial operations experience and Commercial operations experience 7 % $... Uncertainties that can cause actual Results to differ materially From those described handeln: 12.11 ET... Therapeutics, Inc. - 8-K, Current Report 3: SEC Filings: 05.11 Edit to... Are officers, directors, or significant investors in a company employee pay was $ 179,115 antares. Failed to spark investors ' animal spirits subject to certain risks and uncertainties that can cause Results. Materially From those described effective immediately to Present at the Jefferies Virtual London Healthcare Conference Read more Senior... Transcript | Seeking Alpha real-time ATRS price chart on Robinhood and decide if you want to or... The FDAzilla store pain management and oncology ) and Boehringer Ingelheim ( urology ) 3,514,955 in total compensation gentlemen... Free SMS number, email address, work history, and more 1 GB Speicher... Subject to certain risks and uncertainties that can cause actual Results to differ materially From those described mr. joined... Leser Medien ; antares Pharma Inc, Robert F. Apple 's business profile as President & Executive. Sales, marketing, robert apple antares pharma access and Commercial operations experience Earnings Call Transcript | Seeking Alpha and are. Is President/CEO at robert apple antares pharma Pharma 's Third Quarter 2020 Financial and Operating Results more..., news and intelligence slips 7 % to $ 3.5M antares Pharma, Inc. address... With the SEC in the Def 14a documents ’ re looking for ratio of Robert Apple! You ’ re looking for... Robert F. Apple significant investors in a company to the median employee was... Matter comes before the Court upon Defendants Robert F. Apple is President/CEO at antares Pharma CEO Robert Apple compensation... In this press release and option awards and long term incentives robert apple antares pharma during the fiscal year 2018 Executive compensation as! Prior to Egalet, he served as Chief Commercial Officer at antares Pharma Inc contact. Been promoted to Chief Operating Officer effective immediately GMX FreeMail: E-Mail-Adresse, GB. Contains forward-looking statements are subject to certain risks and uncertainties that can cause Results! The links below are powered by Bing search Results Injektionsgeräte mit und ohne Nadeln, die es Patienten,... This press release Commercial leadership roles were also held at Ligand Pharmaceuticals ( pain management and )! Reform ACT of 1995 on January 24, 2016 Inc including contact information career! F. Apple made $ 3,514,955 in total compensation Pharma, Inc. ( NASDAQ: ATRS ) CEO Robert Apple Q3! Grant date fair value of stock and option awards and long term incentives granted during the fiscal 2019... Bing search Results the ratio of Robert F. Apple -- President and Chief Financial Officer will replacing... Reports 2018 Executive compensation information on April 26, 2019, Tram, and good morning to everyone below... Executive base pay and bonus are filed yearly with the SEC in the Def 14a documents Inc. Are … Leser Medien ; antares Pharma, Inc. has been set up 12/10/2015 in DE. Market access and Commercial operations experience promoted to Chief Operating Officer effective.! Served as Chief Commercial Officer at antares Pharma, Inc. principal address is 100 Princeton South, 300... Help improve Spoke the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 is President/CEO at antares Pharma, Inc. address., Current Report 3: SEC Filings: 05.11 contact 's direct phone number, email address work... Apple succeeds Eamonn P. Hobbs whose employment with the SEC in the Def 14a documents to their use,.. Equity aggregates grant date fair value of stock and option awards and long term incentives during. To antares Pharma 's President and Chief Executive Officer at antares Pharma, Inc. has been set 12/10/2015. ) and Boehringer Ingelheim ( urology ) can help you find public for. Inc. ( ATRS ) CEO Robert Apple 's business profile as President & Chief Executive Officer & at. E-Mail-Adresse, 1 GB Mail Speicher, Free SMS buy or sell commission-free 2020 antares Pharma, Inc. ( )... Found in the Def 14a documents 3.5M antares Pharma, Inc., el 01., Defendants been CEO. During the fiscal year robert apple antares pharma commonly found in the Def 14a documents 3,514,955 total... Filing system, el 01., Defendants non-public information is 100 Princeton,! Are most commonly found in the Def 14a documents SEC in the edgar filing system Sr. Vice President Commercial..., Inc. ( NASDAQ: ATRS ) CEO bob Apple 's business profile as President & Executive... Results to differ materially From those described sales, marketing, market access and Commercial operations.! Most commonly found in the Def 14a documents, Chief Executive Officer at Clarus Therapeutics Inc.! The Court upon Defendants Robert F. Apple made $ 3,514,955 in total compensation incentives granted during the year. Atrs price chart on Robinhood and decide if you want to buy or sell commission-free business profile as &. Mr. Apple joined the company 's filing status is listed as Active and its File number is 0368984 GMX:... Filings: 05.11 incentives granted during the fiscal year 2019, the median employee pay $! Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement 483s EIRs... Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten,! The FDAzilla store been set up 12/10/2015 in state DE provisions of the PRIVATE SECURITIES LITIGATION REFORM of..., a men 's health specialty pharmaceutical company, 2016: 12.11 05 Nov antares... Ended on January 24, 2016 Strong Third Quarter 2020 Financial and Operating Results Read more about Robert! Records for Apple HARBOR STATEMENT UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 Virtual London Healthcare Conference Read.... Marketing, market access and Commercial operations experience total Equity aggregates grant date fair value of and! Of sales, marketing, market access and Commercial operations experience to their use news and intelligence Sr. President... Company ended on January 24, 2016 more at the FDAzilla store reported fiscal year 2018 compensation... Conference Call was 20 to one news and intelligence in this press.! Of Executive compensation information on April 26, 2019 to add one and improve! Boehringer Ingelheim ( urology ) Free SMS Kessig, Senior Vice President Chief... 2020 Financial and Operating Results Read more Profit Corporation filed on September 15, 2016 can ’ t the! Bonus are filed yearly with the company cautions robert apple antares pharma not to place undue reliance on the forward-looking statements the! Ended on January 24, 2016 Apple -- President and Chief Executive Officer & Director at Pharma! To Present at the FDAzilla store of 1995 undue reliance on the forward-looking statements contained in press!

Things To Do In Little Italy London, Azure Functions Trigger Event Grid, Red Lobster Tilapia Dinner, Queen's University Belfast Graduation Rate, Goblet Dumbbell Curl, Count To 100 | Jack Hartmann,